Vertex Pharmaceuticals U.S. tax on foreign earnings, net of credits remained flat by 0.0% to -3.1% in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 1900.0%, from 0.2% to -3.1%. This is a positive signal — lower values indicate better performance for this metric.
Lower costs indicate more efficient management of foreign earnings and tax credit utilization.
This metric measures the U.S. tax impact on foreign earnings, net of applicable foreign tax credits. It reflects the tax...
Standard metric for U.S.-based multinationals to reconcile global tax burdens.
other_effective_income_tax_rate_reconciliation_repatriat_10b517| FY'23 | FY'24 | |
|---|---|---|
| Value | 0.7% | -12.6% |
| YoY Change | — | <-999% |